Skip to main content
. 2002 Nov;54(5):522–527. doi: 10.1046/j.1365-2125.2002.01666.x

Table 3.

Levels of concurrent risk factors in patients receiving COX-2 inhibitors.

Cumulative number of risk factors or drug interactions identified in patients Number of patients with concurrent risk factors (%) Number of patients with concurrent drug interactions (%)
0 219 (34.9%) 298 (47.5%)
1 191 (30.5%) 201 (32.1%)
2 154 (24.6%) 90 (14.4%)
3 47 (7.5%) 38 (6.1%)
4 14 (2.2%) 0
5 2 (0.3%) 0